ライフサイエンスコーパス: Affymetrix

1 d using whole-genome expression microarrays (Affymetrix).

2 analyzed by U133 Plus 2.0 expression array (Affymetrix).

3 nscriptome analysis with Gene 1.1 ST Arrays (Affymetrix).

4 Tissues track from tissue data published by Affymetrix.

5 By using Affymetrix 10K chip, we established linkage to chromosom

6 le brain gene expression data (gathered with Affymetrix 430 v2 arrays in the Colorado laboratories) a

7 profiling of PI stimulation was performed on Affymetrix 430A chips, and CN was inhibited via FK506.

8 600 German AgP cases, 1448 controls) and the Affymetrix 500K array set (283 German AgP cases and 972

9 Despite the fact that the SNPs of the Affymetrix 500k chip were ascertained with a bias toward

10 association based on the publicly available Affymetrix 500K genotype data from the Wellcome Trust Ca

11 Using the Affymetrix 500K Mapping array and publicly available gen

12 10-Quad arrays and 112 Mexicans genotyped on Affymetrix 500K platform.

13 ic structure, we obtained and genotyped with Affymetrix 500k SNP arrays DNA samples from 168 self-rep

14 Germline DNA was genotyped using the Affymetrix 500K, Affymetrix 6.0, or the Illumina Exome B

15 eart Study (FHS) participants genotyped with Affymetrix 550K SNPs, we imputed genotypes of same set o

16 of 144 mitochondrial markers as well as the Affymetrix 6.0 (n = 432), Illumina 610-Quad (n = 458), o

17 s for Myopia (SCORM) and simulated data from Affymetrix 6.0 and platform-independent distributions.

18 formed a genome-wide association study using Affymetrix 6.0 array and imputed genotype data.

19 from single-nucleotide polymorphisms from an Affymetrix 6.0 array and we used Cox proportional hazard

20 estry informative markers from a genome-wide Affymetrix 6.0 array in ARIC African Americans yielded s

21 eotide polymorphism (SNP) data utilizing the Affymetrix 6.0 array with imputation to 2.5 million HapM

22 ial single nucleotide polymorphisms from the Affymetrix 6.0 array.

23 Homozygosity mapping using the Affymetrix 6.0 chips demonstrates that all 6 GPS-affecte

24 single-nucleotide polymorphisms based on an Affymetrix 6.0 Gene Chip dataset of 564 German sarcoidos

25 anced AMD cases and 1,709 controls using the Affymetrix 6.0 platform with replication in seven additi

26 Genotyping was performed on the Affymetrix 6.0 platform.

27 739 healthy controls were genotyped with the Affymetrix 6.0 single nucleotide polymorphism (SNP) arra

28 discovery group (n=428) was performed using Affymetrix 6.0 Single-Nucleotide Polymorphism (SNP) Arra

29 d genomic aberrations in PEL cells using the Affymetrix 6.0 SNP array.

30 We used Affymetrix 6.0 SNP arrays to survey common CNVs in a coh

31 orphism genotyping arrays (Illumina 660W and Affymetrix 6.0) and multiplex ligation-dependent probe a

32 DNA was genotyped using the Affymetrix 500K, Affymetrix 6.0, or the Illumina Exome BeadChip array.

33 However, Illumina and Affymetrix algorithms that leverage single nucleotide po

34 Affymetrix analysis identified statistically significant

35 agreement between results obtained using the Affymetrix and Agilent platforms.

36 atasets of lung cancer and brain cancer from Affymetrix and Illumina array platforms, respectively, a

37 tina controls (n= 1272) were genotyped using Affymetrix and Illumina arrays.

38 Affymetrix and Illumina Omni 2.5 platforms were used to

39 leotide polymorphism (SNP) markers from both Affymetrix and Illumina platforms were assayed for all 2

40 show by comparing the integrated analysis of Affymetrix and Illumina SNP array data with Agilent and

41 Data from Affymetrix and Illumina studies were jointly analyzed wi

42 -derived classifiers were tested on separate Affymetrix- and Illumina-based experiments, and collated

43 is was performed from breathing tumors by an Affymetrix approach.

44 Affymetrix array analyses of cultured fibroblasts identi

45 Affymetrix Array experiments revealed 24 differentially

46 Affymetrix array profiling of cDNAs from the osteosarcom

47 Affymetrix array showed a global perturbation in the exp

48 valuated at the RNA and protein levels using Affymetrix array, real-time PCR, and immunoassays.

49 olysomal RNA-based expression profiling with Affymetrix arrays revealed extensive changes in the tran

50 ed network analysis of lung transcriptomics (Affymetrix arrays) in 70 former smokers with COPD to com

51 The transcriptome was determined using Affymetrix arrays.

52 that uses the noise distribution present in Affymetrix arrays.

53 y, genome-wide expression profiling based on Affymetrix ATH1 arrays was used to identify discriminati

54 me network of Arabidopsis thaliana from 3137 Affymetrix ATH1 GeneChips in just 9 min on a 1024-core c

55 Here, we reanalyzed a total of 79 Affymetrix ATH1 microarray studies of redox homeostasis

56 Transcriptome analysis using the Affymetrix ATH1 platform has been completed on purified

57 (UBC9, SAND, PTB, and F-box) identified from Affymetrix ATH1 whole-genome GeneChip studies.

58 cases and 54,566 controls) genotyped on the Affymetrix Axiom European array and a replication phase

59 microarray based on the new highly-efficient Affymetrix Axiom genotyping technology that we are using

60 the development and validation of a 487K SNP Affymetrix Axiom((R)) genotyping array for apple and dis

61 RLMM version 1 and the algorithm provided by Affymetrix, Birdseed.

62 enome-wide association study (SNP Array 6.0, Affymetrix, CA, USA) of NTS bacteraemia in Kenyan childr

63 Utilizing the Affymetrix canine microarray, we are able to definitivel

64 Affymetrix cDNA microarray analysis was conducted to ide

65 An Affymetrix cDNA microarray chip (Pvi_cDNAa520831) contai

66 Analysis of raw microarray data files (e.g. Affymetrix CEL files) can be time consuming, complex, an

67 Using an Affymetrix chip with imputation to 2.5 M single-nucleoti

68 present the R package affy2sv to pre-process Affymetrix CytoScan HD/750k array (also for Genome-Wide

69 addition, previously published L. japonicus Affymetrix data are included in the database, making it

70 After adjusting Affymetrix data to mimic the Agilent experimental design

71 For Affymetrix data, the strongest signal for DBP was rs1047

72 btained by hybridization of messenger RNA to Affymetrix Drosophila Genome 2 microarrays.

73 Contrary to the Affymetrix exon 1.0 array, which only contains four prob

74 The Affymetrix Exon Array is a tool for studying the many pr

75 ap SNPs to gene expression (evaluated by the Affymetrix exon array) in the full set of HapMap CEU (Ca

76 Using a newly designed Affymetrix exon array, with eight probes per exon for ap

77 and AS profiles of 43 pancreas tissues using Affymetrix exon array.

78 Gene expression was assessed with the Affymetrix Exon Array.

79 detect differential splicing events from the Affymetrix exon junction array data.

80 We compared previously perform Affymetrix expression analysis in a subset of samples an

81 By Affymetrix expression analysis, we show that the cytochr

82 Analysis of Affymetrix expression array data revealed that high leaf

83 Affymetrix expression arrays were used to identify diffe

84 We used the 47K GeneChip U133 Plus 2.0 Affymetrix expression microarray platform to obtain re-e

85 testicular germ cell tumor cell lines using Affymetrix expression microarrays and revealed a limited

86 and silver ions (Ag(+)) were analyzed using Affymetrix expression microarrays.

87 The Affymetrix-focused BaFL pipeline takes into account prob

88 targets of miR-192/-194 in vivo we combined Affymetrix gene analysis of liver in which miR-192/-194

89 sue Expression (GTEx) project, consisting of Affymetrix gene arrays and RNA-Seq from over 700 samples

90 Affymetrix gene chip analysis in the three cell populati

91 mRNA expression was measured by Affymetrix gene chips, and differences were analyzed by

92 100PBP were generated and investigated using Affymetrix gene expression arrays and complementary func

93 ed analysis of MethylCap-sequencing data and Affymetrix gene expression microarray data for 30 breast

94 itive element probes present in Illumina and Affymetrix gene expression microarray platforms can accu

95 by the GoldenGate methylation BeadArray and Affymetrix gene expression platforms in 193 MM samples.

96 Affymetrix gene expression profiling done on a series of

97 In this study, we used Affymetrix GeneChip (Affymetrix) to globally assess the

98 A genome-wide association study using Affymetrix GeneChip 100K arrays was performed in a disco

99 ome-wide perspective of ancestry, we analyze Affymetrix GeneChip 500K genotype data from African Amer

100 Affymetrix GeneChip 6.0 DNA arrays were used to genotype

101 The adipogenic capacity was measured by Affymetrix GeneChip and quantitative RT-PCR.

102 microarray data set using the Human HG_U133A Affymetrix GeneChip and RMA normalization there is signi

103 rstand the reactive astrocyte state, we used Affymetrix GeneChip arrays to profile gene expression in

104 An Affymetrix GeneChip consists of an array of hundreds of

105 An analysis of published Affymetrix GeneChip data to detect downstream effectors

106 ridization was conducted as described in the Affymetrix GeneChip Expression Analysis Technical Manual

107 en genome and the subsequent availability of Affymetrix GeneChip genome arrays, several laboratories

108 Galician (northwest Spain) samples using the Affymetrix GeneChip Human 20k cSNP Kit, followed by a re

109 iopsies from 18 breast cancer patients using Affymetrix GeneChip Human Genome U133 Plus 2.0 arrays.

110 cells were compared between groups using the Affymetrix GeneChip hybridization protocol and hierarchi

111 d, the isolated RNA can be used directly for Affymetrix GeneChip labeling or real-time RT-PCR without

112 Genome-wide linkage analysis using Affymetrix GeneChip Mapping 10K data from 12 affected me

113 The Affymetrix GeneChip microarray is currently providing a

114 Affymetrix GeneChip microarrays are the most widely used

115 xpression normalization algorithms exist for Affymetrix GeneChip microarrays.

116 years) and 9 matched controls using both the Affymetrix GeneChip miRNA 2.0 and Human Exon 1.0 ST Arra

117 iRNA expression profiling was performed with Affymetrix GeneChip miRNA 3.0 arrays; and results were v

118 serving as controls were analyzed using the Affymetrix GeneChip miRNA Array.

119 Microarrays were performed using the Affymetrix GeneChip Mouse Genome 430A 2.0 Array.

120 alysed for gene expression by a high-density Affymetrix GeneChip platform, encompassing more than 1 m

121 m >28 000 CEL files relating to 10 different Affymetrix GeneChip platforms and involving nearly 1000

122 paper, we examined the effect of the SNPs on Affymetrix GeneChip probe set summaries and the expressi

123 ver RNA was isolated and microarrayed on the Affymetrix GeneChip Rat Exon 1.0 ST array.

124 Affymetrix GeneChip technology was employed to detect di

125 wing ischemia/reperfusion was examined using Affymetrix GeneChip technology.

126 e performed transcriptome analysis using the Affymetrix GeneChip U133A in gastric cardia adenocarcino

127 d platforms for gene expression microarrays, Affymetrix GeneChip(R) arrays, have as many as ten or mo

128 NanoString nCounter(R) and Affymetrix GeneChip(R) Human Transcriptome Array 2.0 (HT

129 nt, including those unique to seeds, we used Affymetrix GeneChips to profile Arabidopsis genes active

130 We propose a new filtering strategy for Affymetrix GeneChips(R), based on principal component an

131 RNA was processed and hybridized to Affymetrix GeneChips, to determine expression of over 47

132 , have provided insights for the analysis of Affymetrix GeneChips.

133 ol, and participants were genotyped with the Affymetrix Genome-Wide Human SNP 6.0 Array.

134 ects of Mexican ancestry genotyped using the Affymetrix Genome-Wide Human SNP array 5.0.

135 nd an Indian-origin rhesus macaque using the Affymetrix Genome-Wide Human SNP Array 6.0 and cataloged

136 t in the general ASD population, we used the Affymetrix genome-wide human SNP array 6.0 to identify 1

137 We used the Affymetrix Genome-Wide Human SNP Array 6.0 to test for a

138 sequence oligonucleotide arrays are applied (Affymetrix Genome-Wide Human SNP Array 6.0) by evaluatin

139 sing the Illumina Human610-Quad Beadchip and Affymetrix Genome-Wide Human SNP Array 6.0.

140 ed for genomic copy-number variants with the Affymetrix Genome-wide Human SNP Array 6.0.

141 nd local controls (n = 658) genotyped on the Affymetrix Genome-Wide SNP 6.0 Array, along with 2,400 o

142 BAVM cases and 1191 controls genotyped using Affymetrix genome-wide SNP arrays.

143 It is applicable to all Affymetrix genotyping arrays, including the recent ones

144 ral pathway related genes represented on the Affymetrix Grape Genome array indicated 60 were signific

145 Affymetrix has recently developed whole-transcript GeneC

146 ation, and gene expression was assessed with Affymetrix HG-U133 Plus 2.0 GeneChips.

147 Within GEO, the Affymetrix HG-U133A and HG-U133 Plus 2.0 are the two mos

148 5 nonpsoriatic) samples were examined using Affymetrix HG-U95A microarrays.

149 Using a microarray analysis (Affymetrix, High Wycombe, UK), we compared transcriptome

150 al brushings (n = 65) and biopsies (n = 47) (Affymetrix HT HG-U133+ PM).

151 and used Illumina human HT-12 v4 arrays and Affymetrix HTA 2.0 arrays to generate global gene expres

152 RASA was demonstrated with Affymetrix HTAs and its performance was evaluated with m

153 n-lesional sites (n=10) of AA patients using Affymetrix Hu95A-v2 arrays.

154 plant kidney biopsy samples were analyzed by Affymetrix HuGene 1.0 ST expression arrays.

155 s in a subset of patients were studied using Affymetrix HuGene 1.0ST arrays.

156 ood gene expression profiles were studied by Affymetrix Human 1.0 ST GeneChips before and after treat

157 ve nonneoplastic prostate samples, using the Affymetrix Human Array GeneChip Exon 1.0 ST.

158 ay, which uses 50-mer probes, and exon-based Affymetrix Human Exon 1.0 ST array, which uses 25-mer pr

159 plicing were profiled over 12 days using the Affymetrix Human Exon 1.0 ST Array.

160 ramingham Heart Study Offspring Cohort using Affymetrix Human Exon 1.0 ST Array.

161 nd 23 healthy controls (HC) was processed on Affymetrix Human Exon 1.0 ST arrays.

162 We assessed the NCI-60 transcriptome using Affymetrix Human Exon 1.0 ST microarrays and correlated

163 A algorithm to two new microarray platforms--Affymetrix Human Exon and Gene 1.0 ST--by modifying the

164 The Affymetrix Human Exon Junction Array is a newly designed

165 ptome changes following interrogation of the Affymetrix Human Exon ST 1.0 array.

166 condition with a total of 54 separate human Affymetrix Human Gene 1.0 ST array replicates.

167 with and without BK viremia were analyzed by Affymetrix Human Gene 1.0 ST Arrays.

168 rs with and without COPD was performed using Affymetrix Human Gene 1.0 ST Arrays.

169 ene expression profiles were generated using Affymetrix Human Gene 1.1 ST arrays.

170 age cultures of CAF and NF and analyzed with Affymetrix Human Genome U133 Plus 2.0 arrays.

171 annotated gene probe sets represented on the Affymetrix Human Genome U133 plus 2.0 platform.

172 d transcriptome profiling was performed with Affymetrix Human Genome U219 Plate (Affymetrix, Inc., Sa

173 A 2.0 arrays and for genomic variation using Affymetrix Human Mapping 100 K set.

174 th SSc and 564 controls from Korea using the Affymetrix Human SNP Array 5.0.

175 de polymorphisms genotyped using Genome-wide Affymetrix Human SNP Array 6.0 (Affy6.0) and the remaind

176 ed pathway association analysis of KBD using Affymetrix Human SNP Array 6.0 in 1717 Chinese Han subje

177 ti-methylcytidine antibodies and detected by Affymetrix human whole genome SNP 6.0 chips.

178 Amplified mRNA was hybridized to an Affymetrix Human X3P array.

179 identified one genome-wide significant hit (Affymetrix id 1:64178756_C_T; P=1.36 x 10(-11)).

180 a across different microarray platforms from Affymetrix, Illumina and Agilent.

181 Agilent platforms outperformed Illumina and Affymetrix in accuracy and precision of copy number dosa

182 to these BEs, we carried out mRNA profiling (Affymetrix) in mouse mpkCCDc14 collecting duct cells, re

183 med with Affymetrix Human Genome U219 Plate (Affymetrix, Inc., Santa Clara, CA) and miRNA Chip 2.0.

184 vendors: U95A, U133A and U133 Plus 2.0 from Affymetrix, Inc.; HT-12 v1, HT-12v2 and HT-12v3 from Ill

185 gh-throughput platforms such as Illumina and Affymetrix is a critical step in data processing, so tha

186 odify annotation files for the commonly used Affymetrix IVT and Gene/Exon platforms.

187 ion study in 80 cases and 150 controls using Affymetrix Mapping 10K arrays.

188 ma tumor specimens from Asian patients using Affymetrix messenger RNA (mRNA) and NanoString microRNA

189 Affymetrix MicroArray analyses were conducted on human N

190 Using Affymetrix microarray analyses, the global transcriptome

191 Indeed, Affymetrix microarray analysis and immunocytochemistry i

192 We used Affymetrix microarray analysis and validated differentia

193 Using Affymetrix microarray analysis of 102 breast cancers, we

194 Affymetrix microarray analysis of LNCaP and LNCaP-AI (an

195 We therefore performed whole mouse genome Affymetrix microarray analysis of pancreatic gene expres

196 Affymetrix microarray analysis revealed that gamma inter

197 from ovarian ascitic fluids were analysed by Affymetrix microarray analysis, immunoblotting, immunohi

198 or profiling messenger RNA expression, using Affymetrix microarray analysis.

199 PBL gene expression was assessed using Affymetrix microarray and was confirmed by quantitative

200 m of phagocytosis, we used an E. histolytica Affymetrix microarray chip to measure the total gene exp

201 facilitate and standardize Meta-Analysis of Affymetrix Microarray Data analysis (MAAMD) in Kepler.

202 tudy design to generate Illumina RNA-seq and Affymetrix microarray data from the same liver samples o

203 ary cultures was determined by FACS analysis.Affymetrix microarray data indicated that NuMA was overe

204 ation bias from experiments performed on the Affymetrix microarray platform, allowing accurate assess

205 r mRNA profiles were then analyzed using the Affymetrix microarray platform, with validation by quant

206 next-generation sequencing, and Illumina and Affymetrix microarray platforms, to compare the transcri

207 In analysis of our Affymetrix microarray profiling and chromatin immunoprec

208 GF-beta3 are abundant in seminal plasma, and Affymetrix microarray revealed that TGF-beta3 elicits ch

209 Affymetrix microarray showed > 90% similarity in gene ex

210 A was processed for use with the full-genome Affymetrix microarray.

211 e embryonic stem (ES) cells with a prototype Affymetrix microarray.

212 t the average correlations between probes on Affymetrix microarrays are larger for smaller chip dista

213 r Tools and PennCNV-Affy software to analyze Affymetrix microarrays of the first 152,728 genotyped in

214 1 expression in 174 AML trial patients using Affymetrix microarrays showed that the prevalence rate o

215 g donor rats for global gene expression with Affymetrix microarrays, hepatic tissue integrity, viabil

216 m female C57BL/6 mice, analyzed using 1.0 ST-Affymetrix microarrays, revealed extensive activation of

217 gene expression patterns were profiled using Affymetrix microarrays.

218 with untreated cells (P<0.005; FDR=0), using Affymetrix microarrays.

219 animals responding to LPS was profiled using Affymetrix microarrays.

220 enome-scale polymorphism scan using existing Affymetrix microarrays.

221 gene expression profiles were compared using Affymetrix microarrays.

222 d of patients with asthma was measured using Affymetrix microarrays.

223 Affymetrix miRNA profiling was performed on ML collected

224 rum parasites genotyped using a custom-built Affymetrix molecular inversion probe 3K malaria panel ar

225 Total RNA were extracted and profiled on Affymetrix mouse 430 2.0 micro-arrays.

226 and nontransgenic littermate controls using Affymetrix mouse exon arrays.

227 Using Affymetrix mouse exon-arrays, we identified exons with c

228 Affymetrix Mouse Gene 1.0 ST Array profiles were generat

229 sgenic hearts by Illumina RNA sequencing and Affymetrix Mouse Gene 1.0 ST arrays revealed superior dy

230 and analyzed their global gene expression on Affymetrix Mouse Genome 430A microarrays.

231 GeneChip Affymetrix oligonucleotide arrays were used to assess gl

232 n a murine intradermal infection model using Affymetrix oligonucleotide arrays.

233 analyzed 971 stage I/II breast tumors using Affymetrix Oncoscan molecular inversion probe arrays tha

234 MM and BAC for the high-resolution data from Affymetrix platform, but significantly outperforms the o

235 ion (GCH) experiment and performed using the Affymetrix platform, contains two different types of pro

236 minantly HBV-positive cases analyzed with an Affymetrix platform, whereas cohort 2 contained 139 case

237 rified CD4 and CD8 TILs was performed on the Affymetrix platform.

238 1.5 million SNPs, generated by Illumina and Affymetrix platforms in a larger set of individuals.

239 different tumour types, profiled on Agilent, Affymetrix platforms or based on RNA sequencing and avai

240 Genotyping was performed on Illumina and Affymetrix platforms with additional markers imputed to

241 array studies on spotted oligonucleotide and affymetrix platforms.

242 Transcriptional profiling on Affymetrix (porcine) microarrays and real time RT-PCR su

243 Data were normalized using Affymetrix Power Tools and analyzed using commercial mic

244 We used Affymetrix Power Tools and PennCNV-Affy software to anal

245 Transcript data may be accessed using the Affymetrix probe identification number, DNA sequence, ge

246 ethylated DNA immunoprecipitation (MeDIP) on Affymetrix promoter chips to interrogate methylation pro

247 tter, and neostriatum was processed with the Affymetrix(R) array platform.

248 hen perform a comprehensive analysis of 3581 Affymetrix(R) gene expression arrays across 17 diverse b

249 Here, Affymetrix(R) GeneChip miRNA version 1 oligonucleotide m

250 hat depend on the distance between probes on Affymetrix(R) microarrays.

251 lysis of human Ensembl transcripts mapped by Affymetrix(R); and Agilent microarray probes.

252 We compare our method with Affymetrix's CN5 method and the dChip method by assessin

253 calls the vast majority of SNPs in dbSNP and Affymetrix's Genome-Wide Human SNP Array 6.0 up to about

254 de polymorphism analysis was performed using Affymetrix (Santa Clara, CA) platforms.

255 ing expression pattern (Affymetrix U133 2.0; Affymetrix, Santa Clara, CA), DNA change (Affymetrix STY

256 hybridized with the Human Gene ST 1.0 array (Affymetrix, Santa Clara, CA).

257 P6 genotyping and copy number (CN) analysis (Affymetrix, Santa Clara, CA, USA) were used to determine

258 osexual men and 1,231 heterosexual men using Affymetrix single nucleotide polymorphism (SNP) arrays.

259 opy number aberrations, called CNAnova, from Affymetrix SNP 6.0 array data.

260 genotyped by KASPar assay and US patients by Affymetrix SNP 6.0 array.

261 eimer's disease (AD) using data generated on Affymetrix SNP 6.0 arrays and imputed at over 5.7 millio

262 y, we analyzed copy number aberrations using Affymetrix SNP 6.0 arrays in 60 periampullary adenocarci

263 We profiled 251 genomes using Affymetrix SNP 6.0 arrays to determine copy number varia

264 ber changes and loss of heterozygosity using Affymetrix SNP 6.0 arrays, and we correlated genomic les

265 s analyzed for copy number aberrations using Affymetrix SNP 6.0 arrays.

266 s (aCNAs) with the use of ultra-high-density Affymetrix SNP 6.0 arrays.

267 ma and 26 precancerous lesion patients using Affymetrix SNP 6.0 arrays.

268 blood, and 3 cell lines) were analyzed using Affymetrix SNP 6.0 chips.

269 Genotyping with Affymetrix SNP Array 6.0 was performed on two groups of

270 from a family blood pressure study that used Affymetrix SNP Array 6.0.

271 t of more complex pipelines aimed to analyze Affymetrix SNP arrays data in genetic association studie

272 ncer of the Prostate in Sweden (CAPS)] using Affymetrix SNP arrays.

273 f more than 240,000 loci genotyped using the Affymetrix SNP microarray in 554 individuals from 27 wor

274 High-resolution Affymetrix SNP6 genotyping and copy number (CN) analysis

275 ed in peripheral blood with the high-density Affymetrix SNP6.0 microarray platform.

276 yping a known set of variants (e.g. dbSNP or Affymetrix SNPs), is important for characterization of k

277 For Affymetrix SNPs, LAVA has significantly higher SNP calli

278 Microarray analyses using the Affymetrix soybean GeneChip directly compared Peking syn

279 L15, we assessed the transcriptome using the Affymetrix Soybean Genome Array.

280 0; Affymetrix, Santa Clara, CA), DNA change (Affymetrix STY Mapping Array), mutation (CTNNB1), and im

281 We used custom Affymetrix symbiosis chips to characterize the global tr

282 ranscriptional profile was analyzed by using Affymetrix technology.

283 analysis of gene expression was performed by Affymetrix technology.

284 ing sites using a ChIP-chip approach and the Affymetrix tiling arrays for Arabidopsis thaliana and fo

285 trix) with gene expression array (U133A 2.0; Affymetrix) to examine molecular differences between SSM

286 In this study, we used Affymetrix GeneChip (Affymetrix) to globally assess the host cell genes and p

287 sion was assessed with three data sets using Affymetrix U133 + gene chips on normal human colonic muc

288 for each subclass using expression pattern (Affymetrix U133 2.0; Affymetrix, Santa Clara, CA), DNA c

289 time RT-PCR and 61 kidney biopsies using the Affymetrix U133 array.

290 ononuclear cells (PBMCs) were obtained using Affymetrix U133 Plus 2.0 arrays.

291 and 4 normal adrenal glands were profiled on Affymetrix U133 Plus2 expression microarrays to identify

292 RNA was isolated from blood and run on Affymetrix U133 Plus2.0 microarrays.

293 Affymetrix U133+2.0 human microarray chips were used to

294 omitantly analyzed for gene expression using Affymetrix U133A 2.0 arrays and for genomic variation us

295 Whole-blood RNA was hybridised to Affymetrix U133plus2 microarrays.

296 nucleotide polymorphism-array analysis using Affymetrix Version 6.0 on 353 samples from untreated pat

297 ns, using GeneChipp U133 Plus 2 microarrays (Affymetrix), was conducted between October 2012 and Janu

298 omas and 12 sporadic KCOTs was hybridized on Affymetrix whole genome arrays.

299 s single nucleotide polymorphism array (6.0; Affymetrix) with gene expression array (U133A 2.0; Affym

300 Subjects were genotyped on an Affymetrix World Array IV chip.